Found: 11
Select item for more details and to access through your institution.
Four individually druggable MET hotspots mediate HGF-driven tumor progression.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 7, p. 3172, doi. 10.1172/JCI72316
- By:
- Publication type:
- Article
T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 5, p. 503, doi. 10.1007/s00262-005-0001-1
- By:
- Publication type:
- Article
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody (The first two authors contributed equally to this paper.).
- Published in:
- International Journal of Cancer, 2003, v. 105, n. 2, p. 241, doi. 10.1002/ijc.11056
- By:
- Publication type:
- Article
Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody.
- Published in:
- International Journal of Cancer, 2002, v. 100, n. 6, p. 690, doi. 10.1002/ijc.10557
- By:
- Publication type:
- Article
In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment.
- Published in:
- International Journal of Cancer, 2002, v. 100, n. 1, p. 101, doi. 10.1002/ijc.10443
- By:
- Publication type:
- Article
Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2003, v. 129, n. 6, p. 341, doi. 10.1007/s00432-003-0438-6
- By:
- Publication type:
- Article
Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00867
- By:
- Publication type:
- Article
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 178, doi. 10.1002/ajh.25680
- By:
- Publication type:
- Article
The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.
- Published in:
- Biomedicines, 2021, v. 9, n. 6, p. 665, doi. 10.3390/biomedicines9060665
- By:
- Publication type:
- Article
Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2016, v. 29, n. 4, p. 123, doi. 10.1093/protein/gzw003
- By:
- Publication type:
- Article